Illumina share price today

(ILMN)

Illumina share price is $135.21 & ₹11,519.62 as on 25 Dec 2024, 2.30 'hrs' IST

$135.21

▲

0.22

(0.16%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Illumina share price in Dollar and Rupees. Guide to invest in Illumina from India. Also see the sentimental analysis on Indian investors investing in Illumina. Get details on the Indian mutual funds that are investing in Illumina. Get Analyst recommendations and forecasts along with all the Illumina's financials.

Illumina share price movements

Today's Low: $134.55
Today's High: $136.10
$135.21
0.49%
Downside
Day's Volatility :1.14%
Upside
0.65%
52 Weeks Low: $100.09
52 Weeks High: $156.66
$135.21
25.98%
Downside
52 Weeks Volatility :36.11%
Upside
13.69%

Illumina Returns

Period	Illumina Inc.	Sector (Health Care)	Index (NASDAQ Composite)
3 Months	2.22%	-8.7%	10.8%
6 Months	27.01%	-5.0%	13.1%
1 Year	-5.14%	3.2%	33.6%
3 Years	-64.85%	0.0%	28.0%

Illumina Key Statistics

in dollars & INR

Previous Close	$134.99
Open	$134.9
Today's High	$136.1
Today's Low	$134.55
Market Capitalization	$21.4B
Today's Volume	$527.2K
52 Week High	$156.66
52 Week Low	$100.085
Revenue TTM	$4.4B
EBITDA	$730.0M
Earnings Per Share (EPS)	$-9.96
Profit Margin	-36.11%
Quarterly Earnings Growth YOY	-0.96%
Return On Equity TTM	-39.51%

How to invest in Illumina from India?

It is very easy for Indian residents to invest directly in Illumina from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Illumina stock in both Indian Rupees (INR) and US Dollars (USD). Search for Illumina or ILMN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Illumina or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Illumina shares which would translate to 0.006 fractional shares of Illumina as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Illumina, in just a few clicks!

Returns in Illumina for Indian investors in Rupees

Investment Value

₹1,00,000

Illumina investment value today

Current value as on today

₹97,290

Returns

₹2,710

(-2.71%)

Returns from Illumina Stock

₹5,136 (-5.14%)

Dollar Returns

₹2,426 (+2.43%)

Indian investors sentiment towards Illumina

24%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Illumina on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 24% more investors are searching Illumina in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Illumina

Name	Shares Held	Change in Shares	% of Assets
DSP Healthcare Fund Direct Growth	139400	-21944.35	5.23%
ICICI Prudential NASDAQ 100 Index Fund Direct Growth	2064	0.00	0.15%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	223	0.00	0.17%

Global Institutional Holdings in Illumina

BlackRock Inc
11.40%
Vanguard Group Inc
10.03%
State Street Corp
3.54%
Loomis, Sayles & Company LP
2.74%
Baillie Gifford & Co Limited.
2.28%
Capital World Investors
2.23%

Analyst Recommendation on Illumina

Buy

46%Buy

43%Hold

10%Sell

Based on 30 Wall street analysts offering stock ratings for Illumina(by analysts ranked 0 to 5 stars)

Based on 30 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Illumina

What analysts predicted

Upside of 20.94%

Current:

$135.21

Target:

$163.52

Insights on Illumina

Price Movement
In the last 6 months, ILMN stock has moved up by 23.1%
Decreasing Revenue
Revenue is down for the last 2 quarters, 1.11B → 1.08B (in $), with an average decrease of 2.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -1.98B → 705.0M (in $), with an average increase of 382.0% per quarter
ILMN vs DHR (1 yr)
In the last 1 year, Danaher Corp. has given 0.2% return, outperforming this stock by 3.6%
ILMN vs A (3 yr)
In the last 3 years, Illumina Inc. has experienced a drawdown of -64.6%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 36.5%
Price to Sales
ForILMN every $1 of sales, investors are willing to pay $4.9, whereas for Danaher Corp., the investors are paying $7.1 for every $1 of sales.

Illumina Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$3.3B	↑ 21.11%
Net Income	$826.0M	↑ 13.77%
Net Profit Margin	24.78%	↓ 1.6%

	FY19	Y/Y Change
Revenue	$3.5B	↑ 6.3%
Net Income	$1.0B	↑ 21.31%
Net Profit Margin	28.28%	↑ 3.5%

	FY20	Y/Y Change
Revenue	$3.2B	↓ 8.58%
Net Income	$656.0M	↓ 34.53%
Net Profit Margin	20.25%	↓ 8.03%

	FY21	Y/Y Change
Revenue	$4.5B	↑ 39.73%
Net Income	$762.0M	↑ 16.16%
Net Profit Margin	16.84%	↓ 3.41%

	FY22	Y/Y Change
Revenue	$4.6B	↑ 1.28%
Net Income	$-4.4B	↓ 677.95%
Net Profit Margin	-96.07%	↓ 112.91%

	FY23	Y/Y Change
Revenue	$4.5B	↓ 1.75%
Net Income	$-1.2B	↓ 73.64%
Net Profit Margin	-25.78%	↑ 70.29%

	Q2 FY23	Q/Q Change
Revenue	$1.2B	↑ 8.19%
Net Income	$-234.0M	↓ 7900.0%
Net Profit Margin	-19.9%	↓ 20.18%

	Q3 FY23	Q/Q Change
Revenue	$1.1B	↓ 4.85%
Net Income	$-754.0M	↑ 222.22%
Net Profit Margin	-67.38%	↓ 47.48%

	Q4 FY23	Q/Q Change
Revenue	$1.1B	↑ 0.27%
Net Income	$-176.0M	↓ 76.66%
Net Profit Margin	-15.69%	↑ 51.69%

	Q1 FY24	Q/Q Change
Revenue	$1.1B	↓ 4.1%
Net Income	$-126.0M	↓ 28.41%
Net Profit Margin	-11.71%	↑ 3.98%

	Q2 FY24	Q/Q Change
Revenue	$1.1B	↑ 3.35%
Net Income	$-2.0B	↑ 1477.78%
Net Profit Margin	-178.78%	↓ 167.07%

	Q3 FY24	Q/Q Change
Revenue	$1.1B	↓ 2.88%
Net Income	$705.0M	↓ 135.46%
Net Profit Margin	65.28%	↑ 244.06%

	FY18	Y/Y Change
Profit	$2.3B	↑ 25.96%

	FY19	Y/Y Change
Profit	$2.5B	↑ 7.26%

	FY20	Y/Y Change
Profit	$2.2B	↓ 10.7%

	FY21	Y/Y Change
Profit	$3.2B	↑ 43.17%

	FY22	Y/Y Change
Profit	$3.0B	↓ 5.77%

	FY23	Y/Y Change
Profit	$2.7B	↓ 7.67%

	Q2 FY23	Q/Q Change
Profit	$732.0M	↑ 11.76%

	Q3 FY23	Q/Q Change
Profit	$684.0M	↓ 6.56%

	Q4 FY23	Q/Q Change
Profit	$675.0M	↓ 1.32%

	Q1 FY24	Q/Q Change
Profit	$667.0M	↓ 1.19%

	Q2 FY24	Q/Q Change
Profit	$721.0M	↑ 8.1%

	Q3 FY24	Q/Q Change
Profit	$745.0M	↑ 3.33%

	FY18	Y/Y Change
Operating Cash Flow	$1.1B	↑ 30.51%
Investing Cash Flow	$-1.8B	↑ 747.2%
Financing Cash Flow	$594.0M	↓ 437.5%

	FY19	Y/Y Change
Operating Cash Flow	$1.1B	↓ 7.97%
Investing Cash Flow	$745.0M	↓ 141.09%
Financing Cash Flow	$-897.0M	↓ 251.01%

	FY20	Y/Y Change
Operating Cash Flow	$1.1B	↑ 2.76%
Investing Cash Flow	$-554.0M	↓ 174.36%
Financing Cash Flow	$-766.0M	↓ 14.6%

	FY21	Y/Y Change
Operating Cash Flow	$545.0M	↓ 49.54%
Investing Cash Flow	$-1.1B	↑ 92.96%
Financing Cash Flow	$-51.0M	↓ 93.34%

	FY22	Y/Y Change
Operating Cash Flow	$392.0M	↓ 28.07%
Investing Cash Flow	$-591.0M	↓ 44.71%
Financing Cash Flow	$1000.0M	↓ 2060.78%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$105.0M	↑ 950.0%
Investing Cash Flow	$-37.0M	↓ 33.93%
Financing Cash Flow	$-3.0M	↓ 99.37%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$139.0M	↑ 32.38%
Investing Cash Flow	$-146.0M	↑ 294.59%
Financing Cash Flow	$-707.0M	↑ 23466.67%

Illumina Technicals Summary

Sell

Neutral

Buy

Illumina is currently in a neutral trading position according to technical analysis indicators.

Illumina Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Illumina Inc.	-5.41%	27.01%	-5.14%	-64.85%	-58.8%
Idexx Laboratories, Inc.	-0.89%	-16.26%	-25.76%	-36.84%	58.11%
Agilent Technologies Inc.	1.29%	4.05%	-2.66%	-14.26%	60.31%
Thermo Fisher Scientific, Inc.	3.12%	-3.96%	-0.5%	-20.12%	62.74%
Danaher Corp.	-2.46%	-8.35%	-0.91%	-29.52%	50.97%
Iqvia Holdings Inc.	-0.62%	-6.0%	-13.77%	-29.1%	30.33%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Illumina Inc.	91.22	NA	0.62	4.12	-0.4	0.03	NA	13.45
Idexx Laboratories, Inc.	39.84	39.84	4.34	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	30.79	30.79	2.28	5.24	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	32.89	32.89	2.0	21.7	0.13	0.05	0.0	128.08
Danaher Corp.	43.32	43.32	3.06	7.5	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	26.28	26.28	1.05	11.11	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Illumina Inc.	Buy	$21.4B	-58.8%	91.22	-36.11%
Idexx Laboratories, Inc.	Buy	$33.8B	58.11%	39.84	22.53%
Agilent Technologies Inc.	Buy	$38.9B	60.31%	30.79	21.75%
Thermo Fisher Scientific, Inc.	Buy	$200.9B	62.74%	32.89	14.48%
Danaher Corp.	Buy	$165.5B	50.97%	43.32	16.39%
Iqvia Holdings Inc.	Buy	$36.3B	30.33%	26.28	9.17%

About Illumina

at illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. these studies will help make the realization of personalized medicine possible. with such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. as a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. illumina’s innovative, array-based solutions for dna, rna, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

Organization	Illumina
Employees	10590
CEO	Mr. Jacob Thaysen Ph.D.
Industry	Health Technology

Management People of Illumina

Name	Title
Mr. Jacob Thaysen Ph.D.	CEO & Director
Ms. Carissa L. Rollins	Chief Information Officer
Mr. Charles E. Dadswell Esq.	Advisor
Stephanie Campos	President
Mr. Kevin Carl Pegels	Chief of Global Operations
Mr. Scott Ericksen	VP & Chief Accounting Officer
Dr. Steven Barnard Ph.D.	Chief Technology Officer
Ms. Sallilyn Schwartz	Vice President of Investor Relations
Mr. Scott Davies	Interim General Counsel & Secretary
Mr. Jakob Wedel	Chief Strategy & Corporate Development Officer and CEO Chief of Staff

Important FAQs about investing in Illumina from India :

What is Illumina share price today?

Illumina share price today stands at $135.21, Open: $134.90 ; Previous Close: $134.99 ; High: $136.10 ; Low: $134.55 ; 52 Week High: $156.66 ; 52 Week Low: $100.09. The stock opens at $134.90, after a previous close of $134.99. The stock reached a daily high of $136.10 and a low of $134.55, with a 52-week high of $156.66 and a 52-week low of $100.09.

Can Indians buy Illumina shares?

Yes, Indians can invest in the Illumina (ILMN) from India.

With INDmoney, you can buy Illumina at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Illumina at zero transaction cost.

How can I buy Illumina shares from India?

It is very easy to buy Illumina from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Illumina be purchased?

Yes, you can buy fractional shares of Illumina with INDmoney app.

What are the documents required to start investing in Illumina stocks?

To start investing in Illumina, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.